參考文獻/References:
[1] 中國康復(fù)醫(yī)學(xué)會骨質(zhì)疏松預(yù)防與康復(fù)專業(yè)委員會.骨質(zhì)疏松性椎體壓縮骨折診治專家共識(2021版)[J].中華醫(yī)學(xué)雜志,2021,101(41):3371-3379.
[2] DEWAR C.Diagnosis and treatment of vertebral compression fractures[J].Radiol Technol,2015,86(3):301-320.
[3] OLD J L,CALVERT M.Vertebral compression fractures in the elderly[J].Am FamPhysician,2004,69(1):111-116.
[4] 唐任宏,丁慶彬,馮蘭亭,等.骨質(zhì)疏松脊柱骨折女性患者生活質(zhì)量評價及影響因素研究[J].哈爾濱醫(yī)科大學(xué)學(xué)報,2021,55(4):385-389.
[5] WU J,QU Y,WANG K,et al.Healthcare resource utilization and direct medical costs for patients with osteoporotic fractures in China[J].Value Health Reg Issues,2019,18:106-111.
[6] 周風(fēng)鑫.椎體成型術(shù)治療腰椎骨折患者的研究進展[J].醫(yī)療裝備,2021,34(12):193-194.
[7] KLAZEN C A,LOHLE P N,DE VRIES J,et al.Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures(Vertos Ⅱ):an open-label randomised trial[J].Lancet,2010,376(9746):1085-1092.
[8] 李慧彬,王婷婷,張延輝,等.PVP與PKP治療OVCF的研究進展[J].牡丹江醫(yī)學(xué)院學(xué)報,2021,42(6):146-148.
[9] PARK J S,PARK Y S.Survival analysis and risk factors of new vertebral fracture after vertebroplasty for osteoporotic vertebral compression fracture[J].Spine J,2021,21(8):1355-1361.
[10] YOKOYAMA K,KAWANISHI M,YAMADA M,et al.Long-term therapeutic effects of vertebroplasty for painful vertebral compression fracture:a retrospective comparative study[J].Br J Neurosurg,2017,31(2):184-188.
[11] BUCHBINDER R,JOHNSTON R V,RISCHIN K J,et al.Percutaneous vertebroplasty for osteoporotic vertebral compression fracture[J/OL].Cochrane Database Syst Rev,2018,4(4):CD006349[2022-07-02].https://pubmed.ncbi.nlm.nih.gov/29618171/.
[12] HA K Y,KIM Y H.Risk factors affecting progressive collapse of acute osteoporotic spinal fractures[J].Osteoporos Int,2013,24(4):1207-1213.
[13] THEODOROU D J.The intravertebral vacuum cleft sign[J].Radiology,2001,221(3):787-788.
[14] LI Y X,GUO D Q,ZHANG S C,et al.Risk factor analysis for re-collapse of cemented vertebrae after percutaneous vertebroplasty(PVP)or percutaneous kyphoplasty(PKP)[J].Int Orthop,2018,42(9):2131-2139.
[15] MA Y H,TIAN Z S,LIU H C,et al.Predictive risk factors for recollapse of cemented vertebraeafter percutaneous vertebroplasty:a meta-analysis[J].World J Clin Cases,2021,9(12):2778-2790.
[16] YU W,XU W,JIANG X,et al.Risk factors for recollapse of the augmented vertebrae after percutaneous vertebral augmentation:a systematic review and meta-analysis[J].World Neurosurg,2018,111:119-129.
[17] KIM W J,MA S B,SHIN H M,et al.Correlation of sagittal imbalance and recollapse after percutaneous vertebroplasty for thoracolumbar osteoporotic vertebral compression fracture:a multivariate study of risk factors[J].Asian Spine J,2022,16(2):231-240.
[18] ZHANG Z,FAN J,DING Q,et al.Risk factors for new osteoporotic vertebral compression fractures after vertebroplasty:a systematic review and meta-analysis[J].J Spinal Disord Tech,2013,26(4):E150-E157.
[19] 宋春健,周榮,李東.PKP椎體強化治療骨質(zhì)疏松性胸腰椎壓縮骨折后椎體再塌陷的相關(guān)因素分析[J].系統(tǒng)醫(yī)學(xué),2021,6(22):153-156.
[20] 王中英,侯建文,王其尊,等.骨質(zhì)疏松性椎體壓縮骨折PKP術(shù)后長期效果不佳的危險因素分析[J].青島大學(xué)學(xué)報(醫(yī)學(xué)版),2020,56(4):427-431.
[21] 安珍,楊定焯,張祖君,等.骨質(zhì)疏松性脊椎壓縮性骨折流行病學(xué)調(diào)查分析[J].中國骨質(zhì)疏松雜志,2002,8(1):82-83.
[22] HEO D H,CHIN D K,YOON Y S,et al.Recollapse of previous vertebral compression fracture after percutaneous vertebroplasty[J].Osteoporos int,2009,20(3):473-480.
[23] DONG S T,ZHU J,YANG H,et al.Development and internal validation of supervised machine learning algorithm for predicting the risk of recollapse following minimally invasive kyphoplasty in osteoporotic vertebral compression fractures[J/OL].Front Public Health,2022,10:874672[2022-07-02].https://pubmed.ncbi.nlm.nih.gov/35586015/.
[24] BRIGGS A M,GREIG A M,WARK J D,et al.A review of anatomical and mechanical factors affecting vertebral body integrity[J].Int J Med Sci,2004,1(3):170-180.
[25] 郭二松,馬朋朋,張鑫,等.治療骨質(zhì)疏松性椎體壓縮骨折低溫骨水泥的最佳灌注量[J].中國組織工程研究,2023,27(16):2542-2547.
[26] 湯杰,蔡海康,徐鎮(zhèn),等.骨質(zhì)疏松山羊椎體骨水泥強化后對其相鄰椎體生物力學(xué)的影響[J].脊柱外科雜志,2023,21(1):44-49.
[27] AMEIS A,RANDHAWA K,YU H,et al.The global spine care initiative:a review of reviews and recommendations for the non-invasive management of acute osteoporotic vertebral compression fracture pain in low-and middle-income communities[J].Eur Spine J,2018,27(Suppl 6):861-869.
[28] 李哲,蘇慶軍,海涌.伴有椎體內(nèi)裂隙征的骨質(zhì)疏松性椎體壓縮骨折的診治進展[J].中國脊柱脊髓雜志,2017,27(7):647-651.
[29] 李誠,程兆明,張海波.經(jīng)皮椎體后凸成形術(shù)治療伴周壁破裂的骨質(zhì)疏松性胸腰椎骨折[J].脊柱外科雜志,2021,19(3):195-197.
[30] 唐海,陳浩,王炳強,等.椎體后凸成形術(shù)治療重度骨質(zhì)疏松性椎體壓縮骨折[J].中華骨科雜志,2010,30(10):978-983.
[31] KIM Y Y,RHYU K W.Recompression of vertebral body after balloon kyphoplasty for osteoporotic vertebral compression fracture[J].Eur Spine J,2010,19(11):1907-1912.
[32] BELKOFF S M,MATHIS J M,JASPER L E,et al.The biomechanics of vertebroplasty.the effect of cement volume on mechanical behavior[J].Spine(Phila Pa 1976),2001,26(14):1537-1541.
[33] LI D,WU Y,HUANG Y,et al.Risk factors of recompression of cemented vertebrae after kyphoplasty for osteoporotic vertebral compression fractures[J].Int Orthop,2016,40(6):1285-1290.
[34] 孟勝偉,蔣盛旦,蔣雷生.胸腰椎骨質(zhì)疏松性椎體壓縮性骨折椎體強化術(shù)后腰背痛原因的研究進展[J].脊柱外科雜志,2017,15(2):117-122.
[35] HUANG K Y,YAN J J,LIN R M.Histopathologic findings of retrieved specimens of vertebroplasty with polymethylme-thacrylate cement:case control study[J].Spine(Phila Pa 1976),2005,30(19):E585-588.
[36] STANCZYK M,VAN RIETBERGEN B.Thermal analysis of bone cement polymerisation at the cement-bone interface[J].J Biomech,2004,37(12):1803-1810.
[37] 岳晨,任亮,李念虎.椎體骨質(zhì)疏松性壓縮骨折患者PVP/PKP術(shù)后再骨折相關(guān)因素分析[J].世界最新醫(yī)學(xué)信息文摘,2018,18(16):157-158.
[38] 唐本強,王彥輝,許崧杰,等.骨質(zhì)疏松性椎體壓縮骨折經(jīng)皮椎體強化術(shù)后椎體內(nèi)骨水泥分布類型的研究進展[J].中華骨科雜志,2022,42(5):320-330.
[39] 范鑫,許超.PKP術(shù)后椎體高度再丟失臨床研究進展[J].浙江中西醫(yī)結(jié)合雜志,2020,30(2):170-174.
[40] 陳民.經(jīng)皮椎體成形術(shù)后骨水泥強化椎再骨折的臨床研究[D].廣東:暨南大學(xué),2016.
[41] 張圣飛,張亮,陶玉平,等.OVCF骨水泥強化術(shù)后椎體再骨折影響因素分析[J].實用骨科雜志,2019,25(4):293-296.
[42] 邱貴興,裴福興,胡偵明,等.中國骨質(zhì)疏松性骨折診療指南——骨質(zhì)疏松性骨折診斷及治療原則[J].黑龍江科學(xué),2018,9(2):85-88.
[43] YAMAUCHI K,ADACHI A,KAMEYAMA M,et al.A risk factor associated with subsequent new vertebral compression fracture after conservative therapy for patients with vertebral compression fracture:a retrospective observational study[J].Arch Osteoporos,2020,15(1):9.
[44] 中華醫(yī)學(xué)會骨質(zhì)疏松和骨礦鹽疾病分會.原發(fā)性骨質(zhì)疏松癥診療指南(2017)[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2017,10(5):413-444.
[45] HE J,LI X,WANG Z,et al.Therapeutic anabolic and anticatabolic benefits of natural Chinese medicines for the treatment of osteoporosis[J].Front pharmacol,2019,10:1344.
[46] 中國中西醫(yī)結(jié)合學(xué)會骨傷科專業(yè)委員會.骨質(zhì)疏松癥中西醫(yī)結(jié)合診療指南[J].中華醫(yī)學(xué)雜志,2019,99(45):3524-3533.
[47] 吳釩,吳華珍,黃志輝,等.補腎壯骨丸對初次椎體成形術(shù)后傷椎再塌陷的防治作用[J].實用醫(yī)學(xué)雜志,2022,38(1):111-115.
[48] 張斌,胡偉,談榮珍,等.左歸丸聯(lián)合鮭魚降鈣素對老年骨質(zhì)疏松性胸腰椎骨折疼痛療效分析[J].藥品評價,2021,18(17):1062-1064.
[49] 王厚元,謝義松.經(jīng)皮椎體后凸成形術(shù)聯(lián)合獨活寄生湯治療骨質(zhì)疏松性胸腰椎壓縮骨折40例[J].中醫(yī)臨床研究,2021,13(3):103-105.
[50] 徐旭冬,王毅,錢建敏,等.骨愈復(fù)原湯聯(lián)合經(jīng)皮椎體后凸成形術(shù)治療骨質(zhì)疏松性胸腰椎壓縮性骨折臨床研究[J].新中醫(yī),2021,53(19):130-133.
[51] 趙楊,王平,周鑫,等.復(fù)元活血湯加減聯(lián)合PKP治療骨質(zhì)疏松性胸腰椎壓縮骨折對VAS評分及功能恢復(fù)的影響[J].遼寧中醫(yī)雜志,2021,48(9):152-156.
[52] 齊權(quán)律,黃超文,王曉暉,等.補腎益精湯聯(lián)合椎體后凸成形術(shù)治療老年骨質(zhì)疏松性胸腰椎壓縮性骨折及對患者骨代謝指標(biāo)的影響[J].中醫(yī)臨床研究,2021,13(10):66-68.
[53] 周大標(biāo),吳冰心,陽越,等.基于肝脾腎探討絕經(jīng)后骨質(zhì)疏松癥治療機制[J].陜西中醫(yī),2022,43(6):752-754.
[54] HENDRICKX G,BOUDIN E,VAN HUL W.A look behind the scenes:the risk and pathogenesis of primary osteoporosis[J].Nat Rev Rheumatol,2015,11(8):462-474.
相似文獻/References:
[1]張亮,張莉,王莉佳,等.快速康復(fù)外科理念在椎弓根螺釘內(nèi)固定治療
胸腰椎骨折圍手術(shù)期護理中的應(yīng)用[J].中醫(yī)正骨,2015,27(06):75.
[2]潘雄,劉其順,應(yīng)行,等.中藥聯(lián)合4步康復(fù)鍛煉法對骨質(zhì)疏松性椎體壓縮
骨折患者生存質(zhì)量的影響[J].中醫(yī)正骨,2015,27(04):65.
[3]宋永枝,陳雙玲.唑來膦酸靜脈滴注聯(lián)合鮭降鈣素肌肉注射治療
骨質(zhì)疏松性長骨骨折[J].中醫(yī)正骨,2016,28(01):70.
[4]孫蘭芬,王龍強,劉潤宏,等.頸椎骨折脫位合并脊髓損傷截癱患者的圍手術(shù)期護理[J].中醫(yī)正骨,2016,28(03):79.
[5]吳鵬,王博,孔令成,等.強骨飲顆粒聯(lián)合阿侖膦酸鈉維D3片口服在原發(fā)性骨質(zhì)疏松性髖部骨折術(shù)后抗骨質(zhì)疏松治療中的應(yīng)用[J].中醫(yī)正骨,2016,28(05):16.
WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(強骨飲顆粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):16.
[6]梅 偉.胸腰椎骨折臨床診療中的熱點問題[J].中醫(yī)正骨,2016,28(07):1.
[7]徐無忌,劉曉嵐.體位復(fù)位結(jié)合經(jīng)皮椎體成形術(shù)與經(jīng)皮椎體后凸成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折的對比研究[J].中醫(yī)正骨,2016,28(07):20.
XU Wuji,LIU Xiaolan.Effect of Qianggu Yin(強骨飲,QGY)on bone microstructure in the ovariectomized osteoporosis rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):20.
[8]李英周,葉鋒,王曉,等.后路撬撥植骨椎弓根螺釘內(nèi)固定治療胸腰椎骨折[J].中醫(yī)正骨,2016,28(07):46.
[9]王軍,陳哲,王碩凡.胸腰椎骨折椎體植骨材料的臨床應(yīng)用進展[J].中醫(yī)正骨,2016,28(07):64.
[10]史曉林,王健,王博,等.脆性骨折的防治進展[J].中醫(yī)正骨,2017,29(05):20.
[11]陳建德,樊曉琦,夏炳江,等.球囊擴張部位對椎體后凸成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折療效及安全性的影響[J].中醫(yī)正骨,2017,29(02):11.
CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):11.
[12]丁志清,顏峰,喻燦明,等.椎體后凸成形術(shù)后非典型骨水泥植入綜合征死亡1例[J].中醫(yī)正骨,2017,29(11):76.
[13]俞興,王婷,楊濟洲,等.經(jīng)皮椎體成形術(shù)和經(jīng)皮椎體后凸成形術(shù)治療Kmmell病的對比研究[J].中醫(yī)正骨,2018,30(06):23.
YU Xing,WANG Ting,YANG Jizhou,et al.A retrospective trial of percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of Kmmell's diseases[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(05):23.
[14]彭小東,張曉剛,趙文韜,等.有限元分析在過伸復(fù)位治療骨質(zhì)疏松性椎體壓縮性骨折生物力學(xué)研究中的應(yīng)用進展[J].中醫(yī)正骨,2018,30(07):25.
[15]陳建德,樊曉琦,凌義龍.單側(cè)椎弓根旁外側(cè)入路與雙側(cè)椎弓根入路
經(jīng)皮椎體后凸成形術(shù)治療骨質(zhì)疏松性胸椎
壓縮性骨折的對比研究[J].中醫(yī)正骨,2018,30(10):19.
CHEN Jiande,FAN Xiaoqi,LING Yilong.A retrospective trial of percutaneous kyphoplasty through unilateral extrapedicular approach versus bilateral transpedicular approach for treatment of thoracic osteoporotic vertebral compression fracture[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(05):19.
[16]于東方,王祥善,張華,等.經(jīng)皮椎體成形術(shù)后手術(shù)椎體再骨折的病因、治療及預(yù)防[J].中醫(yī)正骨,2018,30(10):69.
[17]李兆勇,楊少鋒,張晨陽.補腎活血方聯(lián)合經(jīng)皮椎體強化術(shù)治療骨質(zhì)疏松性椎體壓縮骨折的系統(tǒng)評價[J].中醫(yī)正骨,2019,31(03):28.
LI Zhaoyong,YANG Shaofeng,ZHANG Chenyang.Oral application of Bushen Huoxue Fang(補腎活血方)combined with percutaneous vertebral augmentation for treatment of osteoporotic vertebral compression fractures:a systematic review[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(05):28.
[18]楊磊,崔宏勛,饒耀劍,等.彎角穿刺椎體成形裝置輔助下單側(cè)穿刺經(jīng)皮椎體成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折[J].中醫(yī)正骨,2020,32(01):64.
[19]陳晨,安忠誠,張英健,等.椎體強化術(shù)后殘留腰背痛的研究進展[J].中醫(yī)正骨,2020,32(05):26.
[20]劉銳,龔德飛,班正濤,等.經(jīng)皮椎體成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折術(shù)中骨水泥滲漏的危險因素分析[J].中醫(yī)正骨,2022,34(11):14.
LIU Rui,GONG Defei,BAN Zhengtao,et al.Risk factors for bone cement leakage during percutaneous vertebroplasty treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(05):14.